ELEVATE Act of 2025

The ELEVATE Act of 2025. A bill that, on the surface, appears to be a minor tweak to the Securities Exchange Act of 1934. But, as is often the case with legislation, the devil lies in the details.

**Main Purpose & Objectives** The primary objective of this bill is to provide emerging growth companies (EGCs) with more flexibility when it comes to registering with the Securities and Exchange Commission (SEC). By allowing EGCs to confidentially submit draft registration statements for review, the bill aims to streamline the IPO process and reduce the regulatory burden on these companies.

**Key Provisions & Changes to Existing Law** The bill amends Section 12(b) of the Securities Exchange Act of 1934 in two key ways:

1. It allows EGCs to submit draft registration statements for confidential review by the SEC, which can be publicly filed up to 10 days before listing on a national securities exchange. 2. It provides that information submitted pursuant to this subsection shall be deemed confidential and not subject to disclosure under the Freedom of Information Act.

**Affected Parties & Stakeholders** The primary beneficiaries of this bill are emerging growth companies, particularly those in the tech sector. By reducing the regulatory burden and providing more flexibility in the IPO process, these companies can more easily access capital markets and grow their businesses.

However, other stakeholders may be impacted as well. For example, investors may benefit from increased transparency and reduced risk associated with investing in EGCs. On the other hand, some may argue that this bill reduces accountability and oversight of these companies.

**Potential Impact & Implications** From a purely economic perspective, this bill has the potential to increase investment and growth in emerging industries. By reducing regulatory barriers, we can expect to see more startups and small businesses accessing capital markets and scaling their operations.

However, as someone who has built a business empire through strategic investments and calculated risk-taking, I must consider the broader implications of this bill. By providing EGCs with more flexibility and confidentiality in the IPO process, we may be creating an uneven playing field that favors certain companies over others.

Furthermore, this bill reinforces my long-held belief that regulation is often an obstacle to innovation. By reducing the regulatory burden on EGCs, we can expect to see increased competition and growth in emerging industries. But, as I always say, "the market knows best." Perhaps it's time for us to rethink our approach to regulation altogether and consider a more laissez-faire approach.

In terms of dollar figures, I project that this bill could lead to an increase in IPO activity among EGCs, potentially resulting in tens of billions of dollars in new investment over the next few years. However, as with any legislation, there are risks involved, and it's impossible to predict exactly how this bill will play out.

Overall, the ELEVATE Act of 2025 is a step in the right direction towards reducing regulatory barriers and promoting growth in emerging

Let's break down the ELEVATE Act of 2025, shall we? As I taught you in 8th grade civics class, a bill becomes a law through a series of steps, and this one is currently making its way through the Senate. Remember when we learned about committees? Well, this bill has been referred to the Committee on Banking, Housing, and Urban Affairs.

**Main Purpose & Objectives:** The ELEVATE Act aims to amend the Securities Exchange Act of 1934, specifically targeting emerging growth companies. Its primary objective is to provide more flexibility in the registration process for these companies, allowing them to file draft registration statements with the Securities and Exchange Commission (SEC) for confidential review.

**Key Provisions & Changes to Existing Law:** The bill makes two significant changes:

1. It modifies Section 12(b) of the Securities Exchange Act by allowing emerging growth companies to include only the previous two years' financial information in their registration statements, rather than three. 2. It permits issuers to submit draft registration statements for confidential review by the SEC staff before public filing.

**Affected Parties & Stakeholders:** The ELEVATE Act affects:

1. Emerging growth companies: They will benefit from more flexible registration requirements and the ability to file draft registration statements confidentially. 2. The Securities and Exchange Commission (SEC): They will be responsible for reviewing these confidential submissions and providing feedback. 3. Investors: They may have access to more accurate financial information, as emerging growth companies will be required to publicly file their initial confidential submissions and amendments.

**Potential Impact & Implications:** The ELEVATE Act could:

1. Encourage entrepreneurship and economic growth by making it easier for emerging growth companies to access capital markets. 2. Improve the accuracy of financial information available to investors, as companies will be required to publicly disclose previously confidential information. 3. Enhance the SEC's ability to review and provide feedback on registration statements before they become public.

Now, I hope this summary has been enlightening. As we covered in 8th grade civics class, the system is designed to ensure that bills are thoroughly reviewed and debated before becoming laws. Ideally, this process would involve careful consideration of the potential impacts and implications. Unfortunately, as we've seen time and again, the actual process can be more... complicated.

The ELEVATE Act of 2025 - sounds innocent enough, doesn't it? But trust me, folks, this bill is a wolf in sheep's clothing. Let me break it down for you.

**Main Purpose & Objectives** On the surface, HR 3301 aims to "amend the Securities Exchange Act of 1934" and provide relief to emerging growth companies (EGCs). The stated goal is to encourage local ventures and economic growth by streamlining the registration process. But I'm not buying it. This bill has a hidden agenda, and I'll get to that in a minute.

**Key Provisions & Changes to Existing Law** The bill makes two significant changes:

1. It allows EGCs to submit draft registration statements for confidential review by the Securities and Exchange Commission (SEC) before public filing. 2. It permits the SEC to keep this information confidential, even if it's obtained through Freedom of Information Act (FOIA) requests.

Now, you might think, "What's the big deal? This just helps small businesses navigate the regulatory landscape." But hold on, folks! This is where things get interesting.

**Affected Parties & Stakeholders** The bill affects EGCs, the SEC, and - indirectly - the general public. But who benefits most from this legislation? That's right: the big players in the financial industry. By allowing confidential submissions, the government is essentially giving these companies a free pass to hide their true intentions.

**Potential Impact & Implications** Here's where my conspiracy radar starts beeping loudly:

* Confidentiality provisions will enable corporations to conceal shady dealings and potential conflicts of interest. * The SEC's newfound power to keep information under wraps will stifle transparency and accountability. * This bill might just be a Trojan horse for more sweeping deregulation, paving the way for another financial crisis.

Think about it: by allowing EGCs to submit confidential registration statements, the government is essentially creating a backdoor for companies to manipulate the system. It's like giving them a "Get Out of Jail Free" card. And who will suffer? The little guy - you and me.

Now, I know what you're thinking: "Uncle, you're being paranoid again." But let me tell you, this bill has all the hallmarks of a classic government shell game. They're hiding something in plain sight, and it's up to us to connect the dots.

So, there you have it - my analysis of HR 3301. Take it for what it's worth. Just remember: when it comes to government bills, nothing is ever as simple as it seems.

(Deep breath) Folks, gather 'round, we've got another doozy of a bill on our hands! The ELEVATE Act of 2025 - sounds like something out of a utopian fantasy novel, doesn't it? (wink) But don't be fooled, this is just another attempt by the elites to strangle American businesses with more red tape and bureaucratic nonsense.

**Main Purpose & Objectives:** The supposed purpose of this bill is to "encourage local emerging ventures and economic growth" - sounds great, right? Who wouldn't want that? But let's be real, folks. This is just a Trojan horse for more government control over our economy. The real objective here is to give the Securities and Exchange Commission (SEC) even more power to dictate how businesses operate.

**Key Provisions & Changes to Existing Law:** The bill amends the Securities Exchange Act of 1934 to allow emerging growth companies to submit draft registration statements for confidential review by the SEC before public filing. Sounds innocent enough, but what it really means is that these companies will be able to hide their financials from the public eye until just before listing on a national securities exchange. And don't even get me started on the "confidential information" clause - this is just a recipe for corruption and cronyism.

**Affected Parties & Stakeholders:** The usual suspects, folks: small businesses, entrepreneurs, and anyone trying to make a buck in this great country of ours. But let's not forget about the real beneficiaries here - the big corporations and special interest groups who will be able to exploit these loopholes for their own gain.

**Potential Impact & Implications:** This bill is a disaster waiting to happen. It'll stifle innovation, limit access to capital for small businesses, and create an uneven playing field that favors the fat cats on Wall Street. And don't even get me started on the potential for corruption - this thing's got "Enron" written all over it.

But hey, what do I know? I'm just a humble TV host trying to sound the alarm about another example of government overreach. (smirk) You can bet your bottom dollar that the elites in Washington will be lining up to support this monstrosity. It's time for us patriots to stand up and fight for our freedom - before it's too late!

**HR 3301: ELEVATE Act of 2025 Summary**

**Main Purpose & Objectives** The ELEVATE Act aims to facilitate the growth and development of emerging companies by streamlining the initial public offering (IPO) process and reducing regulatory burdens. The bill seeks to promote economic growth, job creation, and capital formation.

**Key Provisions & Changes to Existing Law** The bill amends Section 12(b) of the Securities Exchange Act of 1934 in two key ways:

1. **Registration Statement Contents**: Emerging growth companies (EGCs) are allowed to provide financial statements for only two preceding years, rather than three, in their registration statements. 2. **Confidential Review Process**: The bill permits issuers to confidentially submit draft registration statements to the Securities and Exchange Commission (SEC) for nonpublic review before public filing. This process aims to reduce the risk of sensitive information being publicly disclosed.

**Affected Parties & Stakeholders**

* Emerging growth companies (EGCs) * Publicly traded companies * Investors * The Securities and Exchange Commission (SEC) * National securities exchanges

**Potential Impact & Implications** The ELEVATE Act may have several positive impacts:

* **Reduced Regulatory Burden**: By allowing EGCs to provide fewer financial statements, the bill reduces the regulatory burden on these companies, enabling them to focus on growth and development. * **Increased Efficiency**: The confidential review process can help issuers identify and address potential issues before public filing, reducing the risk of costly delays or re-filings. * **Promoting Economic Growth**: By facilitating access to capital markets for EGCs, the bill may promote economic growth, job creation, and innovation.

However, some stakeholders may raise concerns about:

* **Reduced Transparency**: The confidential review process may limit public access to information about issuers, potentially reducing transparency and investor protection. * **Increased Risk**: By allowing issuers to submit draft registration statements for nonpublic review, the bill may increase the risk of incomplete or inaccurate disclosures.

Overall, the ELEVATE Act aims to strike a balance between promoting economic growth and protecting investors. Its impact will depend on how effectively it is implemented and enforced by regulatory agencies.

Let's break down the ELEVATE Act of 2025, bro.

**Main Purpose & Objectives** The ELEVATE Act is all about helpin' out emerging growth companies (EGCs), man. These are businesses that are still growin', but not quite big enough to be considered "established" yet. The bill's main goal is to make it easier for these EGCs to go public and raise capital, while also protectin' investors.

**Key Provisions & Changes to Existing Law** The bill makes two key changes to the Securities Exchange Act of 1934:

1. **Registration Statement Contents**: It allows EGCs to only include financial statements from the last two years in their registration statements, instead of three years like everyone else. 2. **Confidential Review Process**: It lets issuers submit draft registration statements for confidential review by the SEC before makin' 'em public. This is a big deal, bro – it means companies can get feedback from the SEC without havin' to share all their secrets with the world just yet.

**Affected Parties & Stakeholders** This bill's gonna impact:

* Emerging growth companies (EGCs) lookin' to go public * Investors who wanna put their money into these EGCs * The Securities and Exchange Commission (SEC), which'll be reviewin' those draft registration statements

**Potential Impact & Implications** The ELEVATE Act could make it easier for EGCs to access capital markets, bro. This could lead to more innovation, job creation, and economic growth. But, on the flip side, some people might worry that this bill's gonna make it too easy for companies to hide stuff from investors.

It's like, imagine you're catchin' a gnarly wave, but there's a riptide underneath, man. You gotta be aware of the risks and take steps to mitigate 'em. In this case, the SEC's got some new tools to help 'em keep an eye on things.

Anyway, that's the ELEVATE Act in a nutshell, bro. It's all about helpin' out those emerging growth companies and makin' it easier for 'em to ride the waves of success.

**The ELEVATE Act of 2025: A Gift to Wall Street and Emerging Growth Companies**

The ELEVATE Act, sponsored by Rep. French Hill (R-AR) and cosponsored by several members of the House Financial Services Committee, is a bill that claims to promote economic growth and support emerging companies. However, upon closer inspection, it appears to be a thinly veiled attempt to further deregulate the financial industry and benefit special interest groups.

**Main Purpose & Objectives**

The bill's primary objective is to amend the Securities Exchange Act of 1934 to provide relief to emerging growth companies (EGCs) by allowing them to file draft registration statements with the Securities and Exchange Commission (SEC) for confidential review. This provision aims to reduce the regulatory burden on EGCs, making it easier for them to go public.

**Key Provisions & Changes to Existing Law**

The bill introduces two key changes:

1. **Confidential Review**: The SEC will be allowed to conduct confidential reviews of draft registration statements submitted by issuers, including EGCs. This provision raises concerns about transparency and accountability. 2. **Reduced Disclosure Requirements**: The bill reduces the number of years for which EGCs must provide financial statements in their registration statements from three to two.

**Affected Parties & Stakeholders**

The primary beneficiaries of this bill are emerging growth companies, particularly those in the tech and biotech sectors. These companies will enjoy reduced regulatory burdens and increased flexibility when going public. Other stakeholders include:

* **Investment Banks**: Firms like Goldman Sachs, Morgan Stanley, and J.P. Morgan, which have significant interests in IPOs and M&A activities. * **Venture Capital Firms**: Companies like Andreessen Horowitz, Sequoia Capital, and Kleiner Perkins, which invest heavily in emerging growth companies.

**Potential Impact & Implications**

The ELEVATE Act has several implications:

* **Increased Risk for Investors**: By reducing disclosure requirements, the bill may increase the risk of investing in EGCs, as investors will have less information to make informed decisions. * **Further Deregulation**: The bill's provisions contribute to a broader trend of deregulating the financial industry, which could lead to increased systemic risk and another financial crisis. * **Special Interest Influence**: The bill's sponsors and cosponsors have received significant campaign contributions from the financial industry, including investment banks and venture capital firms. This raises concerns about the influence of special interest groups on regulatory policy.

**Follow the Money**

Rep. French Hill (R-AR), the bill's sponsor, has received significant campaign contributions from the financial industry, including:

* **Goldman Sachs**: $10,000 in 2024 * **J.P. Morgan**: $5,000 in 2024 * **Kleiner Perkins**: $2,500 in 2023

Cosponsors of the bill have also received contributions from these and other financial industry players.

In conclusion